Auxergen Inc. Snags Presentation Slot at BIO International 2024 Convention
San Diego, California – March 18, 2024 Auxergen Inc., an innovator in biotechnology based in Maryland, proudly announces its selection for a coveted presentation slot at
Auxergen creates and sells innovative biocontrol solutions that tackle diseases impacting humans, plants, and the environment; our mission is to substantially reduce the chemical strain on our soils and waterways.
Recognized as a Qualified Maryland Biotechnology Company by the Maryland Department of Commerce, we are one of the most widely published companies in ag-bio in America and foster a fertile ground for biotechnological advancements. Maryland has recognized our value year after year as a QMBC, enabling our investors to receive tax incentives for investing in Auxergen and, thereby, propelling Maryland towards a more prosperous, sustainable future.
Mission
To reduce the use of chemical pesticides in agriculture, to reduce toxic runoff and to promote watershed and environmental health. To search for novel applications of discoveries at the nexus of human, animal and plant diseases.
In essence: To create biologic solutions to promote human, animal and environmental health.
Vision:
Pioneering a future where plant bacterial diseases are a relic of the past and human longevity is maximized.
San Diego, California – March 18, 2024 Auxergen Inc., an innovator in biotechnology based in Maryland, proudly announces its selection for a coveted presentation slot at
Baltimore, Maryland – March 11, 2024 Auxergen announces its latest product: an in-vitro assay to measure the pharmacokinetics of THC, CBD and like cannabinoids, which
Baltimore, Maryland – March 11, 2024 Auxergen, Inc. has achieved Qualified Maryland Biotechnology Company (QMBC) status for 2024. QMBC status provides early-stage biotechnology companies with refundable tax
443.887.4110
info@auxergen.com
443.887.4110
info@auxergen.com
Rita Rossi Colwell Center
701 East Pratt Street, Baltimore, MD 21202